NeoGenomics Inc.

NeoGenomics operates a network of cancer-focused genetic testing laboratories that provides genetic and molecular testing services. The company provides testing services to pathologists, oncologists, urologists, hospitals, and other laboratories as well as providing clinical trial services to pharmaceutical firms. The company provides the following types of genetic and molecular testing services: cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry and digital imaging, molecular testing, and pathology consultation. As of Dec 31 2017, the company had laboratory locations in Ft. Myers and Tampa, FL; Aliso Viejo and Fresno, CA; Houston, TX; Nashville, TN; and Rolle, Switzerland.
  • TickerNEO
  • ISINUS64049M2098
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

MarketLine Department

Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report

Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Quest Diagnostics Incorporated (Quest or 'the company') provides diagnostic information services. The company offers diagnostic testing service and clinical trials testing service to physicians and patients through its laboratories and its patient service centers. It also prov...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: Home builders and suppliers continue to outperform and one supplier, MHK, appears to be bottoming. A number of Financial names continue to plod up and to the right (e.g. AMP, AXP, MSCI, RNR) The Technology Sector remains leadership and many names continue to outperform (e.g. SEDG, SNPS, ADBE, TTEC, GPN, PYPL)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders and Auto Parts suppliers continue to stage price and RS reversals. • A number of Industrial Manufacturing are in the process of reversing price and RS downtrends or forming bullish bases. • Semiconductors and Semi-Suppliers continue to be leadership with many breaking topside of bases and staging price and RS reversals.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

As higher lows continue within a broader YTD sideways consolidation, the S&P 500 is poised to retest the 2,790-2,800 horizontal resistance level that we have highlighted in previous reports. While we continue to expect the broad YTD consolidation to continue, below we highlight additional factors that lead to our overall constructive outlook: • XLF bouncing off critical support with authority. We have voiced our concern regarding a potential breakdown below $26.50 on the XLF and the negative implications that it would have on the broad market. We have also noted a failure to break down woul...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch